Generate Biomedicines snaps up $370m Series B

Generate Biomedicines, a provider of a machine learning-powered generative biology platform, has raised $370 million in Series B financing.

Generate Biomedicines, a provider of a machine learning-powered generative biology platform, has raised $370 million in Series B financing. The investors included Flagship Pioneering, Abu Dhabi Investment Authority, the Alaska Permanent Fund, Altitude Life Science Ventures, ARCH Venture Partners, Fidelity Management & Research Company LLC, Morningside Ventures and T. Rowe Price Associates Inc.

Source: Press Release